Device / Technology News

RSS

Technologies for optimizing medication adherence in older adults needed

Avoiding medication-related errors and improving medication adherence among older adults could save the nation billions of dollars and save thousands of lives, according to information included in "Technologies for Optimizing Medication Use in Older Adults," a recent report produced by the non-profit Center for Technology and Aging, and available at www.techandaging.org.

21 Dec 2009

Gore introduces PROPATEN Vascular Grafts with Integrated Rings

W. L. Gore & Associates (Gore) today announced it will expand its line of GORE PROPATEN® Vascular Grafts to include configurations with a unique, all ePTFE radial support that is concealed within the ultra-smooth graft wall and resists kinking and compression. The GORE PROPATEN Vascular Graft with Integrated Rings was introduced at the 2009 AIMsymposiumTM / VEITHsymposiumTM in November in New York City.

21 Dec 2009

ValueOptions employs TriZetto’s Clinical CareAdvance application

The TriZetto Group, Inc. today announced that ValueOptions® Inc., the nation’s largest independent behavioral healthcare and wellness company, recently went live with TriZetto’s Clinical CareAdvance® application 4.41 and expects to launch TriZetto’s Personal CareAdvance® application in early 2010.

21 Dec 2009

Response Biomedical receives USPTO Notice of Allowance for its “Sensitive Immunochromatographic Assay”

Response Biomedical Corporation announced that the Company has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for a continuation of the patent entitled “Sensitive Immunochromatographic Assay”. This patent covers key aspects of Response Biomedical’s lateral flow immunoassays with the proprietary RAMP® testing platform.

21 Dec 2009

TessArae's RM-Flu test granted FDA EUA

TessArae, LLC, a privately held company, and Affymetrix Inc., (NASDAQ:AFFX) today announced that the Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) to TessArae for its TessArray® Resequencing Influenza A Microarray Detection Panel for the Detection of the 2009 H1N1 Influenza A Virus (TessArray RM-Flu test) for the duration of the declaration of emergency unless revoked earlier. The declaration of emergency will expire on April 26, 2010, unless terminated earlier or renewed.

21 Dec 2009

Cermetek Microelectronics launches UL 60601-1 compliant modem module

Cermetek Microelectronics, Inc. today announced the CH24606 modem module. The CH24606, a V.22bis modem module (2400 bits per second), is the first Cermetek modem designed to comply with UL 60601-1 requirements for medical equipment safety. Cermetek has targeted the CH24606 as a low-cost communications solution for medical monitoring equipment. The CH24606 sells for less than $15 in 1000 piece quantities.

21 Dec 2009

FDA clears Dilon Diagnostics' GammaLoc lesion-localization system

Dilon Diagnostics announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its lesion-localization system for molecular imaging biopsy guidance.

21 Dec 2009

Organogenesis files a PMA with the FDA for its CelTx living cell-based technology

Organogenesis, Inc. announced today that it has filed a Premarket Approval Application (PMA) with the U.S. Food and Drug Administration (FDA) for its CelTx(TM), a living cellular construct for oral soft tissue regeneration. If approved, CelTx will be the first, living cell-based technology that is FDA-approved for use in the dental market.

21 Dec 2009

Seattle Genetics and GSK sign ADC collaboration agreement

Seattle Genetics, Inc., announced today that it has entered into a collaboration agreement with GlaxoSmithKline (GSK) under which GSK will pay an upfront fee of $12 million for rights to utilize Seattle Genetics’ antibody-drug conjugate (ADC) technology with multiple antigens to be named by GSK.

21 Dec 2009

Elysium Internet launches new Chiropractor directory

Elysium Internet, Inc., an emerging leader in local performance based advertising and digital media, today announced that it has launched a new local Chiropractor directory under its recently acquired brand www.Chiropractor.net.

21 Dec 2009

Medical physicists converge at ProCure TDC for training in physics of protons and proton therapy

Medical physicists from around the world converged at the ProCure Training and Development Center (TDC) last week for intense training in the physics of protons and proton therapy, an alternative to X-ray radiation for cancer treatment that spares healthy tissue and results in far fewer short- and long-term treatment side effects.

19 Dec 2009

Ontario surpasses federal target for radiation therapy

For the past 12 months, Ontario has surpassed the federal target for radiation therapy wait times, demonstrating that the province has continued to improve access to this important cancer treatment.

19 Dec 2009

Novation names OrthoScan sole supplier of Mini C-Arms

OrthoScan, Inc., a privately held medical device company based in Scottsdale, Arizona today announced that Novation, the healthcare industry's leading contracting services company, has named OrthoScan its sole supplier of Mini C-Arms.

19 Dec 2009

Only half of eligible heart failure patients receive implantable devices

A study of heart failure patients who meet national guidelines for devices that stabilize and strengthen the heart's electrical system found that only half of eligible patients received the devices.

19 Dec 2009

Memorial Blood Centers to showcase its newest bloodmobile

Memorial Blood Centers is pleased to have the opportunity to showcase its newest bloodmobile next Tuesday morning, December 22, 2009 at the City of Duluth Employees Blood Drive.

19 Dec 2009

Annual diabetes Consumer Guide to be published in the January 2010 issue by Diabetes Forecast

When shopping for a new cell phone or even a car, there are dozens of features to explore and choices to make. The same is true of shopping for medical products that will help manage a chronic disease.

19 Dec 2009

HHS announces $60M to address barriers in adopting health IT

David Blumenthal, M.D., Department of Health and Human Services’ (HHS) National Coordinator for Health Information Technology, today announced plans to make available $60 million to support the development of Strategic Health IT Advanced Research Projects (SHARP). SHARP projects will conduct focused research in critical areas where breakthrough advances are needed to address existing barriers to the adoption and meaningful use of health information technology (health IT).

19 Dec 2009

UCLA CNSI and NOF collaborate in novel technologies for nanodelivery of drug therapies

The California NanoSystems Institute at UCLA has announced a new collaboration with Japan-based NOF Corp. to explore initiatives in nanotherapeutics research for new drug-delivery systems.

19 Dec 2009

InHealth to further understand socioeconomic impact of medical devices and diagnostics

As the Institute for Health Technology Studies (InHealth) marks its five-year milestone, the research and educational nonprofit is taking stock of its contributions to objective evidence about the roles that medical technologies play in the economy, in the healthcare system, and in patients' lives.

19 Dec 2009

IRB approves Neuralstem's Phase I trial to treat ALS with spinal cord stem cells

Neuralstem, Inc. today announced that its Phase I trial to treat Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's disease) with its spinal cord stem cells has been approved by the Institutional Review Board (IRB) at Emory University in Atlanta, GA.

19 Dec 2009